I think virus inactivation is a normal vaccination approach and is probably being pursued here? The hardest part is probably growing it in vitro at scale and perhaps ensuring that all of them are inactive.
You don’t need to grow it at scale and out of the two vaccine we have in trials one is adenovirus-based while the other is mRNA-based.
I think virus inactivation is a normal vaccination approach and is probably being pursued here? The hardest part is probably growing it in vitro at scale and perhaps ensuring that all of them are inactive.
You don’t need to grow it at scale and out of the two vaccine we have in trials one is adenovirus-based while the other is mRNA-based.